TotalMarketCap

vTv Therapeutics

VTVTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$86.433 M

$21.86 -9.03%

Close of 6 Nov 2026

As of 6 Nov 2026, vTv Therapeutics (VTVT) has a market capitalization of $86.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$27.0M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #297Perspective TherapeuticsCATX$90.4M
  2. #298Polaryx TherapeuticsPLYX$89.7M
  3. #299vTv TherapeuticsVTVT$86.4M
  4. #300Milestone PharmaceuticalsMIST$86.0M
  5. #301RallybioRLYB$84.7M

What if vTv Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$7,141,474

Per share 326,691× higher

Bitcoin $1.53T

$386,412.72

Per share 17,677× higher

Apple $5.02T

$1,268,557

Per share 58,031× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for vTv Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.